Skip to main content

Advertisement

Log in

The −319C/+49G/CT60G Haplotype of CTLA-4 Gene Confers Susceptibility to Rheumatoid Arthritis in Mexican Population

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Several single nucleotide polymorphisms (SNPs) within the CTLA-4 gene and elevated serum levels of soluble CTLA-4 (sCTLA-4) have been associated with autoimmunity including rheumatoid arthritis (RA). In this case–control study, we evaluated the relationship between the −319C/T (rs5742909) and CT60 G/A (rs3087243) SNPs and sCTLA-4 levels in 200 RA patients and 200 control subjects (CS) from Western Mexico. Both SNPs were genotyped with the polymerase chain reaction–restriction fragment length polymorphism technique and the sCTLA-4 levels were quantified using an enzyme-linked immunosorbent assay kit. In addition, we performed a haplotype analysis, including our previous data of the +49A/G (rs231775) SNP. The G/A genotype of the rs3087243 SNP was associated with a decreased risk of RA [odd ratio (OR) 0.61, 95 % confidence interval (CI) 0.38–0.96, p = 0.024]. This protection was also observed in the negative anti-cyclic citrullinated peptide group of RA carriers of the A allele (OR 0.48, 95 % CI 0.22–1.05, p = 0.042). On the contrary, we identified the −319C/+49G/CT60G haplotype of CTLA-4 gene as a risk factor for RA (OR 1.69, 95 % CI 1.13–2.52, p = 0.01). The sCTLA-4 levels were not associated with RA (p = 0.377), but were correlated with the functional disability of these patients (r = 0.282, p = 0.012). However, in CS the C/T genotype of the rs5742909 SNP, as well as the G/G and G/A genotypes of the rs3087243 SNP were associated with higher sCTLA-4 levels (p < 0.001). In conclusion, our results suggest that the −319C/+49G/CT60G haplotype of CTLA-4 gene is a genetic marker of susceptibility to RA in Western Mexico, whereas the rs3087243 SNP confers protection against this disease. Moreover, both SNPs showed an effect on the sCTLA-4 production in our control population. However, further studies are required to evaluate the role of sCTLA-4 in RA, as well as the molecular and functional basis of the association between both CTLA-4 gene SNPs and soluble levels of CTLA-4 in CS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bax, M., van Heemst, J., Huizinga, T. W., & Toes, R. E. (2011). Genetics of rheumatoid arthritis: what have we learned? Immunogenetics, 63, 459–466.

    Article  PubMed  CAS  Google Scholar 

  2. Korhonen, R., & Moilanen, E. (2009). Abatacept, a novel CD80/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis. Basic & Clinical Pharmacology & Toxicology, 104, 276–284.

    Article  CAS  Google Scholar 

  3. Andersson, A. K., Li, C., & Brennan, F. M. (2008). Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Research & Therapy, 10, 204–212.

    Article  Google Scholar 

  4. Toh, M. L., & Miossec, P. (2007). The role of T cells in rheumatoid arthritis: new subsets and new targets. Current Opinion in Rheumatology, 19, 284–288.

    Article  PubMed  Google Scholar 

  5. Lundy, S. K., Sarkar, S., Tesmer, L. A., & Fox, D. A. (2007). Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Research & Therapy, 9, 202–213.

    Article  Google Scholar 

  6. Verhagen, J., Sabatos, C. A., & Wraith, D. C. (2008). The role of CTLA-4 in immune regulation. Immunology Letters, 115, 73–74.

    Article  PubMed  CAS  Google Scholar 

  7. Yokosuka, T., Kobayashi, W., Takamatsu, M., Sakata-Sogawa, K., Zeng, H., Hashimoto-Tane, A., et al. (2010). Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity, 33, 326–339.

    Article  PubMed  CAS  Google Scholar 

  8. Brand, O., Gough, S., & Heward, J. (2005). HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert Reviews in Molecular Medicine, 7, 1–15.

    Article  PubMed  Google Scholar 

  9. Robert, C., & Ghiringhelli, F. (2009). What is the role of cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma? Oncologist, 14, 848–861.

    PubMed  CAS  Google Scholar 

  10. Cutolo, M., Soldano, S., Montagna, P., Sulli, A., Seriolo, B., Villaggio, B., et al. (2009). CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. Arthritis Research & Therapy, 11, R176–R185.

    Article  Google Scholar 

  11. Kristiansen, O. P., Larsen, Z. M., & Pociot, F. (2000). CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity? Genes and Immunity, 1, 170–184.

    Article  PubMed  CAS  Google Scholar 

  12. Magistrelli, G., Jeannin, P., Herbault, N., De Coignac, A. B., Gauchat, J. F., Bonnefoy, J. Y., et al. (1999). A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. European Journal of Immunology, 29, 3596–3602.

    Article  PubMed  CAS  Google Scholar 

  13. Pawlak, E., Kochanowska, I. E., Frydecka, I., Kiełbiński, M., Potoczek, S., & Bilińska, M. (2005). The soluble CTLA-4 receptor: a new marker in autoimmune diseases. Archivum Immunologiae et Therapiae Experimentalis, 53, 336–341.

    PubMed  CAS  Google Scholar 

  14. Oaks, M. K., Hallett, K. M., Penwell, R. T., Stauber, E. C., Warren, S. J., & Tector, A. J. (2000). A native soluble form of CTLA-4. Cellular Immunology, 201, 144–153.

    Article  PubMed  CAS  Google Scholar 

  15. Wang, X. B., Kakoulidou, M., Giscombe, R., Qiu, Q., Huang, D., Pirskanen, R., et al. (2002). Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. Journal of Neuroimmunology, 130, 224–232.

    Article  PubMed  CAS  Google Scholar 

  16. Liu, M. F., Wang, C. R., Chen, P. C., & Fung, L. L. (2003). Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus. Scandinavian Journal of Immunology, 57, 568–572.

    Article  PubMed  CAS  Google Scholar 

  17. Sato, S., Fujimoto, M., Hasegawa, M., Komura, K., Yanaba, K., Hayakawa, I., et al. (2004). Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis. Rheumatology, 43, 1261–1266.

    Article  PubMed  CAS  Google Scholar 

  18. Wong, C. K., Lit, L. C., Tam, L. S., Li, E. K., & Lam, C. W. (2005). Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology, 44, 989–994.

    Article  PubMed  CAS  Google Scholar 

  19. Luszczek, W., Kubicka, W., Jasek, M., Baran, E., Cisło, M., Nockowski, P., et al. (2006). CTLA-4 gene polymorphisms and natural soluble CTLA-4 protein in psoriasis vulgaris. International Journal of Immunogenetics, 33, 217–224.

    Article  PubMed  CAS  Google Scholar 

  20. Saverino, D., Brizzolara, R., Simone, R., Chiappori, A., Milintenda-Floriani, F., Pesce, G., et al. (2007). Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation. Clinical Immunology, 123, 190–198.

    Article  PubMed  CAS  Google Scholar 

  21. Umemura, T., Ota, M., Hamano, H., Katsuyama, Y., Muraki, T., Arakura, N., et al. (2008). Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. American Journal of Gastroenterology, 103, 588–594.

    Article  PubMed  CAS  Google Scholar 

  22. Simone, R., Brizzolara, R., Chiappori, A., Milintenda-Floriani, F., Natale, C., Greco, L., et al. (2009). A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury. International Immunology, 21, 1037–1045.

    Article  PubMed  CAS  Google Scholar 

  23. Momin, S., Flores, S., Angel, B. B., Codner, D. E., Carrasco, P. E., & Perez-Bravo, F. (2009). Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes. Diabetes Research and Clinical Practice, 83, 289–294.

    Article  PubMed  CAS  Google Scholar 

  24. Toussirot, E., Saas, P., Deschamps, M., Pouthier, F., Perrot, L., Perruche, S., et al. (2009). Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity. Arthritis Research & Therapy, 11, R101–R111.

    Article  Google Scholar 

  25. Simmonds, M. J., & Gough, S. C. (2005). Genetic insights into disease mechanisms of autoimmunity. British Medical Bulletin, 71, 93–113.

    Article  PubMed  Google Scholar 

  26. Ueda, H., Howson, J. M., Esposito, L., Heward, J., Snook, H., Chamberlain, G., et al. (2003). Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423, 506–511.

    Article  PubMed  CAS  Google Scholar 

  27. Fan, L. Y., Tu, X. Q., Cheng, Q. B., Zhu, Y., Feltens, R., Pfeiffer, T., et al. (2004). Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World Journal of Gastroenterology, 10, 3056–3059.

    PubMed  CAS  Google Scholar 

  28. Torres, B., Aguilar, F., Franco, E., Sánchez, E., Sánchez-Román, J., Alonso, J. J., et al. (2004). Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis and Rheumatism, 50, 2211–2215.

    Article  PubMed  CAS  Google Scholar 

  29. van Belzen, M. J., Mulder, C. J., Zhernakova, A., Pearson, P. L., Houwen, R. H., & Wijmenga, C. (2004). CTLA4 +49A/G and CT60 polymorphisms in Dutch coeliac disease patients. European Journal of Human Genetics, 12, 782–785.

    Article  PubMed  Google Scholar 

  30. Ban, Y., Tozaki, T., Taniyama, M., Tomita, M., & Ban, Y. (2005). Association of a CTLA-4 3′ untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Autoimmunity, 38, 151–153.

    Article  PubMed  CAS  Google Scholar 

  31. Zhang, Q., Yang, Y. M., & Lv, X. Y. (2006). Association of Graves’ disease and Graves’ ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene. Journal of Zhejiang University Science B, 7, 887–891.

    Article  PubMed  CAS  Google Scholar 

  32. Mayans, S., Lackovic, K., Nyholm, C., Lindgren, P., Ruikka, K., Eliasson, M., et al. (2007). CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC Medical Genetics, 8, 3–10.

    Article  PubMed  Google Scholar 

  33. Chang, M. C., Chang, Y. T., Tien, Y. W., Liang, P. C., Jan, I. S., Wei, S. C., et al. (2007). T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clinical Chemistry, 53, 1700–1705.

    Article  PubMed  CAS  Google Scholar 

  34. Kavvoura, F. K., Akamizu, T., Awata, T., Ban, Y., Chistiakov, D. A., Frydecka, I., et al. (2007). Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 92, 3162–3170.

    Article  PubMed  CAS  Google Scholar 

  35. Balbi, G., Ferrera, F., Rizzi, M., Piccioli, P., Morabito, A., Cardamone, L., et al. (2007). Association of −318 C/T and +49A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. Clinical and Experimental Immunology, 149, 40–47.

    Article  PubMed  CAS  Google Scholar 

  36. Chong, K. K., Chiang, S. W., Wong, G. W., Tam, P. O., Ng, T. K., Hu, Y. J., et al. (2008). Association of CTLA-4 and IL-13 gene polymorphisms with Graves’ disease and ophthalmopathy in Chinese children. Investigative Ophthalmology & Visual Science, 49, 2409–2415.

    Article  Google Scholar 

  37. Dallos, T., Avbelj, M., Barák, L., Zapletalová, J., Pribilincová, Z., Krajcírová, M., et al. (2008). CTLA-4 gene polymorphisms predispose to autoimmune endocrinopathies but not to celiac disease. Neuroendocrinology Letters, 29, 334–340.

    PubMed  CAS  Google Scholar 

  38. Bicek, A., Zaletel, K., Gaberscek, S., Pirnat, E., Krhin, B., Stopar, T. G., et al. (2009). 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease. Human Immunology, 70, 820–824.

    Article  PubMed  CAS  Google Scholar 

  39. Jin, P., Xiang, B., Lin, J., Huang, G., Zhou, W. D., Zheng, C., et al. (2009). Association of CTLA-4 +49A/G and CT60 gene polymorphism with type 1 diabetes and thyroid autoimmunity. Zhonghua Yi Xue Za Zhi, 89, 1246–1249.

    PubMed  CAS  Google Scholar 

  40. Lei, C., Dongqing, Z., Yeqing, S., Oaks, M. K., Lishan, C., Jianzhong, J., et al. (2005). Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. European Journal of Human Genetics, 13, 823–828.

    Article  PubMed  Google Scholar 

  41. Plenge, R. M., Padyukov, L., Remmers, E. F., Purcell, S., Lee, A. T., Karlson, E. W., et al. (2005). Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. American Journal of Human Genetics, 77, 1044–1060.

    Article  PubMed  CAS  Google Scholar 

  42. Gonzalez-Escribano, M. F., Rodriguez, R., Valenzuela, A., Garcia, A., Garcia-Lozano, J. R., & Nuñez-Roldan, A. (1999). CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens, 53, 296–300.

    Article  PubMed  CAS  Google Scholar 

  43. Lee, Y. H., Choi, S. J., Ji, J. D., & Song, G. G. (2002). No association of polymorphisms of the CTLA-4 exon 1 (+49) and promoter (−318) genes with rheumatoid arthritis in the Korean population. Scandinavian Journal of Rheumatology, 31, 266–270.

    Article  PubMed  Google Scholar 

  44. Barton, A., Jury, F., Eyre, S., Bowes, J., Hinks, A., Ward, D., et al. (2004). Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis and Rheumatism, 50, 748–752.

    Article  PubMed  CAS  Google Scholar 

  45. Orozco, G., Torres, B., Núñez-Roldán, A., González-Escribano, M. F., & Martín, J. (2004). Cytotoxic T-lymphocyte antigen-4-CT60 polymorphism in rheumatoid arthritis. Tissue Antigens, 64, 667–670.

    Article  PubMed  CAS  Google Scholar 

  46. Zhernakova, A., Eerligh, P., Barrera, P., Wesoly, J. Z., Huizinga, T. W., Roep, B. O., et al. (2005). CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Human Genetics, 118, 58–66.

    Article  PubMed  CAS  Google Scholar 

  47. Suppiah, V., O’Doherty, C., Heggarty, S., Patterson, C. C., Rooney, M., & Vandenbroeck, K. (2006). The CTLA4 +49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland. Experimental and Molecular Pathology, 80, 141–146.

    Article  PubMed  CAS  Google Scholar 

  48. Torres-Carrillo, N., Torres-Carrillo, N. M., Vázquez-Del Mercado, M., Rangel-Villalobos, H., Parra-Rojas, I., Sánchez-Enríquez, S., et al. (2008). Distribution of -844 G/A and Hind III C/G PAI-1 polymorphisms and plasma PAI-1 levels in Mexican subjects: comparison of frequencies between populations. Clinical and Applied Thrombosis/Hemostasis, 14, 220–226.

    Article  PubMed  CAS  Google Scholar 

  49. Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., et al. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism, 31, 315–324.

    Article  PubMed  CAS  Google Scholar 

  50. Cardiel, M. H., Abello-Banfi, M., Ruiz-Mercado, R., & Alarcon-Segovia, D. (1993). How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI). Clinical and Experimental Rheumatology, 11, 117–121.

    PubMed  CAS  Google Scholar 

  51. Leeb, B. F., Andel, I., Sautner, J., Bogdan, M., Maktari, A., Nothnagl, T., et al. (2005). Disease activity measurement of rheumatoid arthritis: comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine. Arthritis and Rheumatism, 53, 56–60.

    Article  PubMed  Google Scholar 

  52. Fleiss, J. L. (1981). Statistical methods for rates and proportions (2nd ed., pp. 38–45). New York: Wiley.

    Google Scholar 

  53. Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.

    Article  PubMed  CAS  Google Scholar 

  54. Excoffier, L., & Slatkin, M. (1995). Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Molecular Biology and Evolution, 12, 921–927.

    PubMed  CAS  Google Scholar 

  55. Lewontin, R. C. (1964). The interaction of selection and linkage. I. General considerations; heterotic models. Genetics, 49, 49–67.

    PubMed  CAS  Google Scholar 

  56. Gavrilets, S. (2001). Population genetics: multilocus. Encyclopedia of Life Sciences (pp. 1–5). Chichester: Wiley.

    Google Scholar 

  57. Lander, E., & Kruglyak, L. (1995). Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genetics, 11, 241–247.

    Article  PubMed  CAS  Google Scholar 

  58. Muñoz-Valle, J. F., Valle, Y., Padilla-Gutiérrez, J. R., Parra-Rojas, I., Rangel-Villalobos, H., del Mercado, M. V., et al. (2010). The +49A >G CTLA-4 polymorphism is associated with rheumatoid arthritis in Mexican population. Clinica Chimica Acta, 411, 725–728.

    Article  Google Scholar 

  59. Szibor, R. (2007). X-chromosomal markers: past, present and future. Forensic Science International Genetics, 1, 93–99.

    Article  PubMed  Google Scholar 

  60. Wang, X. B., Zhao, X., Giscombe, R., & Lefvert, A. K. (2002). A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein. Genes and Immunity, 3, 233–234.

    Article  PubMed  Google Scholar 

  61. Ligers, A., Teleshova, N., Masterman, T., Huang, W. X., & Hillert, J. (2001). CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes and Immunity, 2, 145–152.

    Article  PubMed  CAS  Google Scholar 

  62. Kouki, T., Sawai, Y., Gardine, C. A., Fisfalen, M. E., Alegre, M. L., & DeGroot, L. J. (2000). CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. Journal of Immunology, 165, 6606–6611.

    CAS  Google Scholar 

  63. Han, S., Li, Y., Mao, Y., & Xie, Y. (2005). Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis. Human Genetics, 118, 123–132.

    Article  PubMed  CAS  Google Scholar 

  64. Ahmed, S., Ihara, K., Kanemitsu, S., Nakashima, H., Otsuka, T., Tsuzaka, K., et al. (2001). Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford), 40, 662–667.

    Article  CAS  Google Scholar 

  65. Seidl, C., Donner, H., Fischer, B., Usadel, K. H., Seifried, E., Kaltwasser, J. P., et al. (1998). CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens, 51, 62–66.

    Article  PubMed  CAS  Google Scholar 

  66. Hadj Kacem, H., Bellassoued, M., Bougacha-Elleuch, N., Abid, M., & Ayadi, H. (2001). CTLA-4 gene polymorphisms in Tunisian patients with Graves’ disease. Clin Immunol, 101, 361–365.

    Article  PubMed  CAS  Google Scholar 

  67. Anjos, S., Nguyen, A., Ounissi-Benkalha, H., Tessier, M. C., & Polychronakos, C. (2002). A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. Journal of Biological Chemistry, 277, 46478–46486.

    Article  PubMed  CAS  Google Scholar 

  68. Daroszewski, J., Pawlak, E., Karabon, L., Frydecka, I., Jonkisz, A., Slowik, M., et al. (2009). Soluble CTLA-4 receptor an immunological marker of Graves’ disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms. European Journal of Endocrinology, 161, 787–793.

    Article  PubMed  CAS  Google Scholar 

  69. Karabon, L., Kosmaczewska, A., Bilinska, M., Pawlak, E., Ciszak, L., Jedynak, A., et al. (2009). The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease. Immunology, 128, e787–e796.

    Article  PubMed  Google Scholar 

  70. Wan, B., Nie, H., Liu, A., Feng, G., He, D., Xu, R., et al. (2006). Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol, 177, 8844–8850.

    PubMed  CAS  Google Scholar 

  71. Purohit, S., Podolsky, R., Collins, C., Zheng, W., Schatz, D., Muir, A., et al. (2005). Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes. Journal of Autoimmune Disease, 2, 8–13.

    Article  Google Scholar 

  72. Cao, J., Zou, L., Luo, P., Chen, P., & Zhang, L. (2012). Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis. International Immunopharmacology, 14, 585–592.

    Article  PubMed  CAS  Google Scholar 

  73. Berry, A., Tector, M., & Oaks, M. K. (2008). Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms. Journal of Negative Results in Biomedicine, 7, 8–11.

    Article  PubMed  Google Scholar 

  74. de Moor, C. H., Meijer, H., & Lissenden, S. (2005). Mechanisms of translational control by the 3′ UTR in development and differentiation. Seminars in Cell & Developmental Biology, 16, 49–58.

    Article  Google Scholar 

  75. Torres-Carrillo, N., Torres-Carrillo, N. M., Martínez-Bonilla, G. E., Vázquez-Del Mercado, M., Palafox-Sánchez, C. A., Oregón-Romero, E., et al. (2009). Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis. Clin Exp Med, 9, 223–228.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by Grant No. 69235 to JFMV of the National Council of Science and Technology (CONACyT, México-Universidad de Guadalajara).

Conflict of Interest

None of the authors have any potential financial conflict of interest related to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Francisco Muñoz-Valle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Torres-Carrillo, N., Ontiveros-Mercado, H., Torres-Carrillo, N.M. et al. The −319C/+49G/CT60G Haplotype of CTLA-4 Gene Confers Susceptibility to Rheumatoid Arthritis in Mexican Population. Cell Biochem Biophys 67, 1217–1228 (2013). https://doi.org/10.1007/s12013-013-9640-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-013-9640-6

Keywords

Navigation